Navigation Links
ARIUS announces second quarter fiscal 2008 financial results
Date:7/11/2008

-

Leasehold inducement - -

Non-cash stock-based

compensation 866,895 434,620

Accretion of convertible

debentures - -

Loss on extinguishment of

debt - -

Services received for common

shares - -

Write-off of investment - -

Interest expense paid in

common shares - -

Change in non-cash operating

working capital items (674,854) 1,221,090

---------------------------------------------------------

(6,000,304) (3,541,381)

Financing activities:

Issue of shares, warrants and

units, net of issuance costs 305,486 -

Issuance of convertible bridge

loan, net - -

Repayment of convertible bridge

loan, including costs - -

Exercise of compensation

warrants 1,697,446 -

Exercise of stock options 153,917 -

Draw of bank line of credit - -

Repayment of bank line of

credit - -

Bridge loan - -

Repayment of bridge loan - -

Repayment of capital lease

and equipment financing

obligations (12,630) (17,433)

---------------------------------------------------------

2,144,219 (17,433)

Investing activities:

Purchase of short-term

in
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ARIUS presents new findings for anti-cancer antibody programs at AACR
2. ARIUS announces first quarter fiscal 2008 financial results
3. ARIUS 2008 Annual and Special Meeting of Shareholders
4. ARIUS recognized for entrepreneurial excellence
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
7. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
8. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
9. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 PathoGenetix, Inc., a ... strain typing, announced today that it has successfully identified ... coli strains obtained from the Centers for Disease Control ... (GSS™) technology. The findings are detailed in a ... American Society for Microbiology in Denver on Monday. , ...
(Date:5/20/2013)... 21, 2013 Grace Century , ... “game-changing” life science and health related private equity projects, ... its International Project Team. Dergham's expertise in finance and ... depth to Grace Century as it continues to look ... Ms. Dergham holds both an under graduate degree from ...
(Date:5/20/2013)... Calif. , May 20, 2013  (PSHR) ... providing naturally based products across a broad range ... company has retained investor relations firm, BlueWater Advisory ... the return to trading process, and to direct ... trading initiation. Matthew Mills ...
(Date:5/20/2013)... , Md. and BALTIMORE , ... (BHI), a regional private-public partnership focusing on ... early-stage funding in Central Maryland ... Ph.D., M.B.A., as the first Entrepreneur-in-Residence (EIR) for ... National Heart, Lung and Blood Institute ...
Breaking Biology Technology:New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4
... , NEW YORK, ... AOB ), ("the Company" or "AOBO"), a pharmaceutical,company ... of a broad range of prescription and over the ... drugs have been included,in China,s National (Medical) Insurance Catalog ...
... , - BioMS Medical makes ... and EDMONTON, Dec. 17 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX: ... BioMS Medical ("BioMS") and a syndicate of investors have invested ... advance Toraymyxin(TM), a treatment for severe sepsis, towards regulatory approval ...
... to detect chemical agents and illegal drugs which will help ... The devices will use special gel pads to ,swipe, an ... then analysed by a scanning instrument that can detect the ... decisions to be made in response to terrorist threats. ...
Cached Biology Technology:American Oriental Bioengineering Announces the Inclusion of 158 Drugs in China's National Insurance Catalog 2American Oriental Bioengineering Announces the Inclusion of 158 Drugs in China's National Insurance Catalog 3Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis 2Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis 3Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis 4Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis 5Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis 6New technology detects chemical weapons in seconds 2
(Date:5/21/2013)... the way genes function without changing the underlying ... blood of pregnant women during any trimester, potentially ... the weeks after giving birth, and an opportunity ... findings of the small study involving 52 pregnant ... Molecular Psychiatry . , "Postpartum depression can be ...
(Date:5/20/2013)... of Minnesota Medical School researchers from the Masonic Cancer ... Brain Tumor Program, have developed a new mouse model ... them to discover new genes and gene pathways driving ... this week in the journal Nature Genetics . ... the lab of David Largaespada, Ph.D., professor in the ...
(Date:5/20/2013)... of the planet, inhales carbon dioxide as it exudes oxygen. ... that eventually fall to the ground to decompose or get ... recently people believed much of the rain forest,s carbon floated ... ocean. University of Washington research showed a decade ago that ... open the question of how that was possible, since bark ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3U of M researchers develop model for better testing, targeting of MPNST 2Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3
... new studies have shown that a unique program in ... health skills and gain a better understanding of medical ... interest in college attendance and medical careers among the ... at the American Public Health Association (APHA) Annual Meeting ...
... are 1/100,000 the width of a human hair to deliver ... may sound like something out of a science fiction movie, ... near future. Carbon nanotubes, cylindrically shaped carbon ... potential applications in a variety of fields, such as biomedical ...
... research published today by a University of Cincinnati faculty ... earlier, a finding he attributes, at least in part, ... service associate professor, has spent countless hours walking the ... last 18 years to survey hundreds of different plant ...
Cached Biology News:Program for young students increases interest in college attendance and medical careers 2Nanotechnology: A dead end for plant cells? 2Budding research links climate change and earlier flowering plants 2
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
...
... microplate readers combines reagent dispensing with fluorescence, ... easy-to-use platform for the complete range of ... and adaptability of the Infinite 200 series ... monochromator (M200) or filter (F200) system and ...
Piperazine-N',N'-bis(2-ethanesulfonic acid), monosodium salt...
Biology Products: